James A. Bianco, President and CEO at CTI BIOPHARMA CORP (CTIC), sold 10,000 shares at $0.45 ($5K) on 2016-05-27, disclosed to the SEC on 2016-05-27.
Scheduled sale ($4k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CTIC | SELL | 2016-03-30 | $5K | — | Filing → |
| CTIC | SELL | 2016-03-23 | $350K | — | Filing → |
| CTIC | SELL | 2016-02-26 | $6K | — | Filing → |